Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Miller, Vincent A."'
Autor:
Chu, Lisa Pei, Franck, Debra, Parachoniak, Christine A, Gregg, Jeffrey P, Moore, Michael G, Farwell, D Gregory, Rao, Shyam, Heilmann, Andreas M, Erlich, Rachel L, Ross, Jeffrey S, Miller, Vincent A, Ali, Siraj, Riess, Jonathan W
Publikováno v:
The oncologist, vol 24, iss 10
Identification of effective targeted therapies for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains an unmet medical need. A patient with platinum-refractory recurrent oral cavity HNSCC underwent comprehensive genomic profil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::07ecfb6bc34e2d5fff114cb58ca88889
https://escholarship.org/uc/item/80p9g6zz
https://escholarship.org/uc/item/80p9g6zz
Autor:
Brown, Benjamin P, Zhang, Yun-Kai, Westover, David, Yan, Yingjun, Qiao, Huan, Huang, Vincent, Du, Zhenfang, Smith, Jarrod A, Ross, Jeffrey S, Miller, Vincent A, Ali, Siraj, Bazhenova, Lyudmila, Schrock, Alexa B, Meiler, Jens, Lovly, Christine M
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 11
PurposeThe third-generation EGFR inhibitor, osimertinib, is the first mutant-selective inhibitor that has received regulatory approval for the treatment of patients with EGFR-mutant lung cancer. Despite the development of highly selective third-gener
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::619883a05ad31222812c787253668161
https://escholarship.org/uc/item/2qw3n28j
https://escholarship.org/uc/item/2qw3n28j
Autor:
Schrock, Alexa B, Welsh, Allison, Chung, Jon H, Pavlick, Dean, Bernicker, Eric H, Creelan, Benjamin C, Forcier, Brady, Ross, Jeffrey S, Stephens, Philip J, Ali, Siraj M, Dagogo-Jack, Ibiayi, Shaw, Alice T, Li, Tianhong, Ou, Sai-Hong Ignatius, Miller, Vincent A
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol 14, iss 2
IntroductionGenomic profiling informs selection of matched targeted therapies as part of routine clinical care in NSCLC. Tissue biopsy is the criterion standard; however, genomic profiling of blood-derived circulating tumor DNA (ctDNA) has emerged as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::12fd293c1a5b276ab7973e559e7b8ef4
https://escholarship.org/uc/item/17q9s90h
https://escholarship.org/uc/item/17q9s90h
Publikováno v:
Miller, Vincent P.; Quigley, John M.; & Wiseman, Michael L.(1988). Segregation by Racial and Demographic Group: Evidence from the San Francisco Bay Area. UC Berkeley: Fisher Center for Real Estate and Urban Economics. Retrieved from: http://www.escholarship.org/uc/item/2k51h9fx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::f106fd7e23846b23e1fdc74586c45aaf
http://www.escholarship.org/uc/item/2k51h9fx
http://www.escholarship.org/uc/item/2k51h9fx